GALENICA AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.98 CHF | +0.78% |
|
+0.07% | +1.65% |
| May. 23 | Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... |  |
| May. 23 | Swiss Market Index Closes Little Changed; Julius Bär Gains | MT |
| Sales 2024 * | 3.93B 4.34B | Sales 2025 * | 4.08B 4.51B | Capitalization | 3.66B 4.04B |
|---|---|---|---|---|---|
| Net income 2024 * | 174M 192M | Net income 2025 * | 184M 203M | EV / Sales 2024 * | 1.07 x |
| Net Debt 2024 * | 532M 588M | Net Debt 2025 * | 504M 557M | EV / Sales 2025 * | 1.02 x |
| P/E ratio 2024 * |
21.1
x | P/E ratio 2025 * |
19.8
x | Employees | 6,181 |
| Yield 2024 * |
3.12% | Yield 2025 * |
3.23% | Free-Float | 99.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on Galenica AG
More recommendations
| 1 day | -0.27% | ||
| 1 week | -1.81% | ||
| Current month | -0.20% | ||
| 1 month | -1.74% | ||
| 3 months | -0.61% | ||
| 6 months | +0.89% | ||
| Current year | +0.89% |
1 week
72.70
74.80
1 month
72.5075.40
Current year
69.3078.15
1 year
65.1078.15
3 years
60.5582.20
5 years
50.1082.20
10 years
41.8082.20
| Managers | Title | Age | Since |
|---|---|---|---|
Marc Werner
CEO | Chief Executive Officer | 57 | - |
| Director of Finance/CFO | 58 | 09-12-31 | |
Lukas Ackermann
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Etienne Jornod
CEO | Chief Executive Officer | 71 | 95-12-31 |
Jörg Zulauf
BRD | Director/Board Member | 66 | 23-05-10 |
| Director/Board Member | 62 | 16-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.18% | 5 M€ | -.--% | - | |
| 0.17% | 1,056 M€ | +1.13% | ||
| 0.07% | 775 M€ | -.--% | - | |
| 0.02% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 73.95 | +0.75% | 16 953 |
| 24-07-02 | 73.4 | -0.27% | 58,771 |
| 24-07-01 | 73.6 | +0.07% | 60,575 |
| 24-06-28 | 73.55 | -1.08% | 85,291 |
| 24-06-27 | 74.35 | +0.61% | 105,162 |
Delayed Quote Swiss Exchange, July 02, 2024 at 11:30 am EDT
More quotes
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
Pharmaceuticals
Calendar
2024-08-05
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
73.4
CHF
Average target price
77
CHF
Spread / Average Target
+4.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.89% | 4.05B | |
| +26.32% | 75.86B | |
| -4.23% | 23.51B | |
| +15.24% | 8.76B | |
| +1.71% | 8.31B | |
| -33.21% | 6.66B | |
| +19.66% | 5.45B | |
| -8.73% | 3.8B | |
| -9.28% | 3.33B | |
| +8.56% | 3.22B |
- Stock Market
- Equities
- GALE Stock
